Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Chemotherapy and Chemoradiotherapy for Gastric Cancer
NCT00525785Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jan 2004
- Primary completion
- Jan 2016
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in gastric cancer (GC), sponsored by University of Texas MD Anderson Cancer Center. Started Jan 2004; status: completed.
02
Drugs
oxaliplatin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00525785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00525785.